Scopus
🔓 Açık Erişim YÖKSİS Eşleşti
Evaluation of medication and herbal product use among pregnant women
Acta Pharmaceutica Sciencia · Ocak 2021
YÖKSİS Kayıtları
Evaluation of Medication and Herbal Product Use Among Pregnant Women
Acta Pharmaceutica Sciencia · 2021 Scopus
DOKTOR ÖĞRETİM ÜYESİ CENGİZHAN CEYLAN →
Makale Bilgileri
DergiActa Pharmaceutica Sciencia
Yayın TarihiOcak 2021
Cilt / Sayfa59 · 575-588
Scopus ID2-s2.0-85117902580
Erişim🔓 Açık Erişim
Özet
The use of medications and herbal products among women increases after pregnancy. The purpose of the study is to evaluate the frequency of medication used and analyzed them based on the FDA pregnancy risk categories. This cross-sectional study was conducted on 300 adult volunteers attending antenatal care in a university-affiliated hospital. Medications were classified according to the FDA pregnancy risk classification. In 97,7% of women, the use of at least one medication during pregnancy. The median count for Category A medications was 2. Category C and B medications were reported by 100 (33,3%) and 53 women (17,7%). There was a significant difference between the education level and the use of herbal products (p=0.043). Pharmacists should take a greater role in educating pregnant women and women of childbearing age about the possible consequences of medications on the development of the fetus and guide healthcare practitioners in choosing the most appropriate medications.
Yazarlar (5)
1
Rashida Muhammad Umar
ORCID: 0000-0001-8902-7274
2
Rabia Beşiroğlu
ORCID: 0000-0003-3188-4278
3
Ayşe Kevser Şahin
ORCID: 0000-0003-0223-2959
4
Emine Karataş Koçberber
ORCID: 0000-0003-2803-0992
5
Cengizhan Ceylan
ORCID: 0000-0003-4164-9212
Anahtar Kelimeler
FDA risk category
Herbal product use
Medication use
Pregnancy
Kurumlar
İstanbul Medipol Üniversitesi
Istanbul Turkey
Marmara Üniversitesi
Istanbul Turkey
Selçuk Üniversitesi
Selçuklu Turkey
Metrikler
1
Atıf
5
Yazar
4
Anahtar Kelime